SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending after plunging following a Q4 earnings miss and weak 2026 outlook, which also led to a CEO change. While many investors are in capitulation, others view the dramatic drop to 2017 price levels as an extreme overreaction, highlighting the company's strong cash flow, low valuation, and ongoing share buybacks as a potential deep value opportunity.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is surging after robust earnings that exceeded expectations and significantly raised full-year guidance, fueled by accelerating U.S. commercial revenue, prompting bulls to laud its AI leadership while skeptics still debate its rich valuation.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending ahead of its upcoming Q4 earnings report, sparking a sharp division within the community between those who see the stock as deeply undervalued given its large user base and new AR initiatives, and others who express frustration over its consistent decline and management's perceived inability to drive sustained profitability despite significant revenue growth.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULF is soaring after announcing the acquisition of two strategic sites, more than doubling its digital and power capacity to 2.8 GW, a move seen as a significant acceleration into AI and high-performance computing. Investors are aggressively discussing a potential short squeeze and a major re-valuation as the company pivots to meet hyperscaler demand.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending due to significant insider selling following lock-up expirations, sparking intense debate among investors about whether the stock is an oversold bargain or an "IPO scam" amid broader software sector weakness and AI disruption concerns.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to CEO Ryan Cohen's hints at a 'monumental acquisition' of a publicly listed retailer, igniting intense community debate between bulls anticipating a short squeeze and skeptics wary of another potential 'rug pull' or dilution.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors digest its Q4 earnings beat and promising mid-stage results for its monthly obesity drug, PF3944, which showed significant weight loss, yet community discussion reveals widespread frustration over the stock's price performance despite favorable news, leading to sustained calls for leadership changes.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is drawing attention after its subsidiary secured a $5.6 billion U.S. Army contract, though the stock is caught in a wider software sector sell-off as the community actively discusses whether AI will disrupt or instead bolster the company's deeply integrated enterprise solutions.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending amidst a strategic push into AI infrastructure, underscored by its completed Celestial AI acquisition and significant partnerships with Microsoft and Amazon for custom chips, fueling a community divide between palpable frustration over persistent stock underperformance and strong conviction in its deep undervaluation and future AI growth.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing a significant surge, with bulls attributing the rebound to positive ISM Manufacturing PMI and a new US-India trade deal, while a vocal segment of the community views the rally as a "fake pump" and "manipulation" amidst concerns over the delayed jobs report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ocugen (NASDAQ:OCGN) Trading 12.4% Higher - Time to Buy?

Ocugen (NASDAQ:OCGN) Trading Up 12.4% - What's Next...

Ocugen (OCGN) Stock Tumbles After $22.5 Million Share Offering

Ocugen shares sank sharply Wednesday after the biotech company announces a $22.5 million underwritten offering of common stock.read more...

Ocugen's (OCGN) "Buy" Rating Reiterated at Chardan Capital

Chardan Capital reissued a "buy" rating and set a $7.00 price objective on shares of Ocugen in a report on Tuesday...

Ocugen, Inc. (NASDAQ:OCGN) Short Interest Update

Ocugen, Inc. (NASDAQ:OCGN - Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totaling 46,392,427 shares, a decline of...

Ocugen Stock Is Surging Today: What's Driving The Action?

Ocugen Inc (NASDAQ:OCGN) shares are up on Friday as the company is gaining traction following positive market sentiment.read more...

Ocugen's Early Gene Therapy Data Shows 46% Drop In Vision Damage

Ocugen reports early phase 2 data showing its eye gene therapy reduced lesion growth by up to 54%, with no serious safety issues.read more...

Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last?

Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Ocugen (NASDAQ:OCGN) Shares Up 9% - Time to Buy?

Ocugen (NASDAQ:OCGN) Trading 9% Higher - Should You Buy...

<ul class="summary-bullets"><li>Ocugen stated that, in six patients with gradable Fundus Auto Fluorescence images, atrophic lesion growth was reduced by 54% in eyes treated with its therapy compared to untreated eyes.</li><li>The company added that lesion expansion was 50% slower in treated eyes than in eyes that did not receive treatment.</li><li>Ocugen also reported that every eye treated with its therapy showed either stabilization or improvement in visual acuity.</li></ul>Ocugen Inc. (OCGN) shares rose nearly 3% pre-market on Monday after the company announced results in its gene therapy trial for Stargardt patients with no options.Ocugen announced positive Phase 1 GARDian1 trial results for OCU410ST, its novel modifier gene therapy for Stargardt disease. This disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe combined, the company said.<h2 class="st-heading-2">Ocugen Trial Update</h2>In its Phase 1 GARDian1 trial update, Ocugen reported that, among six patients with gradable Fundus Auto Fluorescence images, atrophic lesion growth was reduced by 54% in eyes treated with its therapy compared to untreated eyes.The company added that lesion expansion was 50% slower in treated eyes compared to those that did not receive the treatment. Ocugen also reported that every eye treated with its therapy showed either stabilization or improvement in visual acuity.Lastly, the company stated that there were no drug-related serious adverse events, nor were adverse events of special interest observed.<h2 class="st-heading-2">Retail Upbeat</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/OCGN">Ocugen</a> edged up over the past 24 hours, hovering in the ‘bullish’ territory at the time of writing, while message volume was at ‘high’ levels.One bullish user stated that traders were not as excited about Ocugen as they should be.<stembedurl>https://stocktwits.com/HandsomeBull1/message/641502007</stembedurl><a href="https://stocktwits.com/symbol/OCGN">OCGN stock</a> is up 11% year-to-date and 81% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/abvx-soars-pre-market-on-reports-of-17-5-billion-eli-lilly-takeover-interest/cmU9zJNR4E2">ABVX Soars Pre-Market On Reports Of $17.5 Billion Eli Lilly Takeover Interest</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

OCGN Stock Rises Pre-Market After Gene Therapy Data Shows Promise In Rare Eye Disorder

Stargardt disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe combined.

Equity

Ocugen Stock Surges 75% Year to Date: What's in Store for 2026?

Ocugen rises 75% YTD as it advances three gene therapies, with multiple phase II/III readouts and filings lined up for 2026.

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Ocugen Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $UBER earnings on Wednesday?

OCGN
Ocugen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest OCGN News

OCGNOcugen Inc